[Articles] The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial

Di |2024-10-24T00:30:01+02:00Ottobre 24th, 2024|Categorie: Coronavirus Lancet|

Interference between passive immunity and vaccine response is clinically significant and might affect the implementation of next-generation CSP-based vaccines for young infants and mothers as well as passive immunisation with human monoclonal antibodies.

[Articles] Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial

Di |2024-10-24T00:30:01+02:00Ottobre 24th, 2024|Categorie: Coronavirus Lancet|

Boosting mRNA-immunised adults with ARCT-2301 induced superior immunogenicity compared with Comirnaty BA.4-5 against both Wuhan-Hu-1 and omicron BA.4/5 variant COVID-19, and elicited a higher response against omicron XBB.1.5. Both vaccines had similar ...

[Corrections] Correction to Lancet Infect Dis 2024; published online Oct 7. https://doi.org/10.1016/S1473-3099(24)00615-7

Di |2024-10-19T00:30:01+02:00Ottobre 19th, 2024|Categorie: Coronavirus Lancet|

Oda Y, Kumagai Y, Kanai M, et al. 12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine. Lancet Infect Dis 2024; published online Oct 7. https://doi.org/10.1016/S1473-3099(24)00615-7—In thi...

[Corrections] Correction to Lancet Infect Dis 2024; published online Oct 7. https://doi.org/10.1016/S1473-3099(24)00615-7

Di |2024-10-19T00:30:01+02:00Ottobre 19th, 2024|Categorie: Coronavirus Lancet|

Oda Y, Kumagai Y, Kanai M, et al. 12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine. Lancet Infect Dis 2024; published online Oct 7. https://doi.org/10.1016/S1473-3099(24)00615-7—In thi...

[Corrections] Correction to Lancet Infect Dis 2024; published online Sept 27. https://doi.org.10.1016/S1473-3099(24)00618-2

Di |2024-10-19T00:30:01+02:00Ottobre 19th, 2024|Categorie: Coronavirus Lancet|

Brickley EB, Miranda-Filho DdB, Ximenes RAdA, on behalf of the MERG, ZBC-Consortium, and LIFE Zika Study members. Preparing for the rapid research response to the possible vertical transmission of Oropouche virus: lessons from a decade of congenital Zi...

[Corrections] Correction to Lancet Infect Dis 2024; published online Sept 27. https://doi.org.10.1016/S1473-3099(24)00618-2

Di |2024-10-19T00:30:01+02:00Ottobre 19th, 2024|Categorie: Coronavirus Lancet|

Brickley EB, Miranda-Filho DdB, Ximenes RAdA, on behalf of the MERG, ZBC-Consortium, and LIFE Zika Study members. Preparing for the rapid research response to the possible vertical transmission of Oropouche virus: lessons from a decade of congenital Zi...

Torna in cima